In the context of NAFLD, steatotic hepatocytes exhibit a strong response to IL-17A, leading to the upregulation of IL-17RA and increased production of proinflammatory and fibrogenic cytokines (e.g., IL-6 and TNF-α) (55–57). This evidence concerns the gene IL17A and metabolic dysfunction-associated steatotic liver disease.